Diagnostics & Research
The Diagnostics & Research industry has a total of 63 stocks, with a combined market cap of $787.13 billion, total revenue of $155.93 billion and a weighted average PE ratio of 58.95.
Market Cap
787.13B
Revenue
155.93B
Profits
13.35B
PE Ratio
58.95
Profit Margin
8.56%
Dividend Yield
0.19%
63 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 226.74B | -0.22% | 630,250 | 42.49B |
| 2 | DHR | Danaher Corporation | 197.84B | -0.23% | 38,778 | 22.52B |
| 3 | A | Agilent Technologies, Inc. | 45.32B | 0.27% | 693,309 | 6.74B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 43.78B | -2.46% | 517,277 | 3.72B |
| 5 | IQV | IQVIA Holdings Inc. | 41.92B | -0.47% | 648,956 | 15.07B |
| 6 | MTD | Mettler-Toledo International Inc. | 32.43B | -0.29% | 124,051 | 3.79B |
| 7 | ICLR | ICON PLC | 26.35B | 1.27% | 347,378 | 8.23B |
| 8 | WAT | Waters Corporation | 21.00B | -0.54% | 402,918 | 2.91B |
| 9 | LH | Laboratory Corporation of America Holdings | 17.43B | -1.79% | 583,474 | 12.30B |
| 10 | ILMN | Illumina, Inc. | 17.29B | -2.29% | 1,680,595 | 4.49B |
| 11 | DGX | Quest Diagnostics Incorporated | 16.02B | -0.12% | 1,042,168 | 9.29B |
| 12 | RVTY | Revvity, Inc. | 13.82B | 1.62% | 864,343 | 2.73B |
| 13 | NTRA | Natera, Inc. | 13.06B | -0.14% | 1,003,963 | 1.21B |
| 14 | MEDP | Medpace Holdings, Inc. | 12.31B | 1.00% | 98,203 | 1.96B |
| 15 | CRL | Charles River Laboratories International, Inc. | 11.49B | 0.65% | 457,285 | 4.11B |
| 16 | QGEN | Qiagen N.V. | 10.07B | -0.48% | 1,084,943 | 1.94B |
| 17 | EXAS | Exact Sciences Corporation | 9.41B | 1.23% | 4,854,398 | 2.53B |
| 18 | RDNT | RadNet, Inc. | 4.32B | 1.81% | 270,581 | 1.66B |
| 19 | SHC | Sotera Health Company | 3.14B | -1.77% | 445,644 | 1.08B |
| 20 | GH | Guardant Health, Inc. | 3.03B | -2.33% | 2,827,454 | 603.73M |
| 21 | OLK | Olink Holding AB (publ) | 2.98B | -0.08% | 51,888 | 170.89M |
| 22 | NEOG | Neogen Corporation | 2.96B | 0.96% | 1,733,221 | 929.24M |
| 23 | TWST | Twist Bioscience Corporation | 2.61B | -4.55% | 832,164 | 277.49M |
| 24 | MYGN | Myriad Genetics, Inc. | 2.26B | -1.11% | 762,393 | 774.20M |
| 25 | NEO | NeoGenomics, Inc. | 1.90B | 0.74% | 565,822 | 610.66M |
| 26 | VCYT | Veracyte, Inc. | 1.70B | -2.53% | 545,910 | 375.47M |
| 27 | LAB | Standard BioTools Inc. | 988.27M | 0.39% | 2,028,742 | 126.76M |
| 28 | OPK | OPKO Health, Inc. | 920.03M | - | 2,369,140 | 799.60M |
| 29 | CDNA | CareDx, Inc | 814.07M | 0.84% | 573,354 | 275.11M |
| 30 | CSTL | Castle Biosciences, Inc. | 688.52M | 2.89% | 410,853 | 250.73M |
| 31 | FLGT | Fulgent Genetics, Inc. | 650.55M | -1.67% | 131,651 | 287.53M |
| 32 | SERA | Sera Prognostics, Inc. | 266.48M | 1.82% | 108,870 | 206.00K |
| 33 | ME | 23andMe Holding Co. | 263.96M | -6.85% | 7,847 | 247.99M |
| 34 | BDSX | Biodesix, Inc. | 180.06M | -0.32% | 110,843 | 54.85M |
| 35 | PRPH | ProPhase Labs, Inc. | 99.97M | 4.17% | 24,727 | 28.72M |
| 36 | TTOO | T2 Biosystems, Inc. | 93.12M | 7.45% | 303,128 | 7.18M |
| 37 | FONR | FONAR Corporation | 91.05M | -5.58% | 59,204 | 102.72M |
| 38 | ACRS | Aclaris Therapeutics, Inc. | 84.81M | - | 304,669 | 31.12M |
| 39 | BNR | Burning Rock Biotech Limited | 81.45M | -6.27% | 6,491 | 75.80M |
| 40 | MDXH | MDxHealth SA | 77.50M | -1.39% | 14,800 | 75.33M |
| 41 | STIM | Neuronetics, Inc. | 75.89M | -3.07% | 69,823 | 73.23M |
| 42 | PSNL | Personalis, Inc. | 75.83M | 4.29% | 161,173 | 74.15M |
| 43 | PRE | Prenetics Global Limited | 74.16M | 5.02% | 13,776 | 21.74M |
| 44 | VNRX | VolitionRx Limited | 61.87M | -2.97% | 153,432 | 797.03K |
| 45 | ENZ | Enzo Biochem, Inc. | 56.86M | 1.83% | 42,387 | 12.81M |
| 46 | NOTV | Inotiv, Inc. | 47.79M | -4.66% | 700,345 | 552.74M |
| 47 | OCX | OncoCyte Corporation | 36.89M | -5.80% | 19,432 | 1.38M |
| 48 | XGN | Exagen Inc. | 32.49M | -0.53% | 33,238 | 55.73M |
| 49 | AWH | Aspira Women's Health Inc. | 31.62M | -4.51% | 64,650 | 8.99M |
| 50 | BIAF | bioAffinity Technologies, Inc. | 25.88M | -1.77% | 48,471 | 4.94M |
| 51 | PMD | Psychemedics Corporation | 15.07M | 0.60% | 765 | 21.60M |
| 52 | STRR | Star Equity Holdings, Inc. | 14.38M | 3.09% | 164,744 | 42.56M |
| 53 | MYNZ | Mainz Biomed B.V. | 13.54M | -8.22% | 226,424 | 895.48K |
| 54 | CHEK | Check-Cap Ltd. | 12.75M | -0.91% | 2,030 | - |
| 55 | DMTK | DermTech, Inc. | 12.59M | -27.91% | 3,151,323 | 15.66M |
| 56 | TRIB | Trinity Biotech plc | 11.46M | - | 15,734 | 56.83M |
| 57 | GENE | Genetic Technologies Limited | 10.62M | -0.87% | 10,183 | 5.78M |
| 58 | CNTG | Centogene N.V. | 10.61M | 2.86% | 398,353 | 53.93M |
| 59 | PRPO | Precipio, Inc. | 8.82M | -3.85% | 1,950 | 15.81M |
| 60 | XWEL | XWELL, Inc. | 6.82M | -6.32% | 18,776 | 31.77M |
| 61 | NDRA | ENDRA Life Sciences Inc. | 3.53M | 4.20% | 114,001 | - |
| 62 | ISPC | iSpecimen Inc. | 2.48M | 3.07% | 124,436 | 9.27M |
| 63 | APDN | Applied DNA Sciences, Inc. | 1.93M | -21.91% | 321,933 | 5.52M |